Global Atorvastatin Calcium Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Atorvastatin Calcium market size was valued at US$ 260 million in 2024 and is forecast to a readjusted size of USD 424 million by 2031 with a CAGR of 7.3% during review period.

Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8.

The key players of global Atorvastatin Calcium include Pfizer, DSM Sinochem Pharmaceuticals, Ind-Swift, Cadila Pharmaceuticals, Morepen and Sun Pharmaceutical Industries. Pfizer is the leader of this industry with about 26% market shares. India and China are the main consumption bases, and India holds 35% consumption share, and China holds 18% consumption share. They occupy 54% of the global consumption in total.

This report is a detailed and comprehensive analysis for global Atorvastatin Calcium market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Atorvastatin Calcium market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (K USD/MT), 2020-2031

Global Atorvastatin Calcium market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (K USD/MT), 2020-2031

Global Atorvastatin Calcium market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (K USD/MT), 2020-2031

Global Atorvastatin Calcium market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (K USD/MT), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Atorvastatin Calcium

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Atorvastatin Calcium market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, DSM Sinochem Pharmaceuticals, Ind-Swift, Cadila Pharmaceuticals, Morepen, Sun Pharmaceutical Industries, MSN Laboratories, Dr. Reddy's, Teva Pharmaceutical Industries, Apotex Pharmachem, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Atorvastatin Calcium market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Chemical Synthesis
Biocatalysis

Market segment by Application
Tablet (Including Dispersible Tablet and General Tablet)
Capsule
Others

Major players covered
Pfizer
DSM Sinochem Pharmaceuticals
Ind-Swift
Cadila Pharmaceuticals
Morepen
Sun Pharmaceutical Industries
MSN Laboratories
Dr. Reddy's
Teva Pharmaceutical Industries
Apotex Pharmachem
Zheijang Neo-Dankon Pharmaceutical
Ningbo Menovo Pharmaceuticals Group
Jialin Pharmaceutical
Topfond
Zhejiang Hisun Pharmacutical
Zhejiang Hongyuan Pharmaceutical
Hubei Yitai Pharmaceutical
Jiangsu Hengrui Medicine

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Atorvastatin Calcium product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Atorvastatin Calcium, with price, sales quantity, revenue, and global market share of Atorvastatin Calcium from 2020 to 2025.

Chapter 3, the Atorvastatin Calcium competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Atorvastatin Calcium breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Atorvastatin Calcium market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Atorvastatin Calcium.

Chapter 14 and 15, to describe Atorvastatin Calcium sales channel, distributors, customers, research findings and conclusion.